Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2024-08-15 00:00:00 ET · period of report 2024-08-13 · accession 0001714899-24-000177 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-15 | 2024-08-13 | DNLI | Schuth Alexander O. | COFO, Sec | S - Sale | $22.89 | -2,272 | 186.4K | -1% | -$52.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-13 | S | D | 2,272 | $22.89 | 186,419 | D | — | — | (F3) Includes 1,350 shares acquired under the ESPP Purchase on May 31, 2024. (F2) Includes 123,810 RSUs. |